FCI Ophthalmics is announcing a New & Improved Self-Retaining Bicanaliculus Intubation Set, designed by Pierre Bigé, MD.
Nicknamed the SRSII, this new and innovative stent allows the physician to intubate the canaliculi in the office with just topical anesthetic drops.
The SRSII enables intubation of the upper and lower canaliculi without having to enter through the nasal passageway. The 0.64 mm wide tube is made of medical grade silicone and is available in three lengths – 25 mm, 30 mm and 35 mm. Each end of the tube is has an anchor-shaped head with two flexible winglets that fold inward during insertion through the punctum. Insertion is now made easier with pre-loaded introducers on each end. After passage through the common canaliculus, the winglets open in the lacrimal sac for secure fixation. A centrally placed marking on the tube acts as a reference point and allows verification of proper stent positioning.
Primary indications for the SRSII include horizontal lacrimal duct stricture or punctal stenosis. Special consideration should be given to cancer patients on constricting drug therapies such as Taxotere®.
For more information on the SRSII contact FCI Ophthalmics.
FCI OPHTHALMICS
20 Winter St.
Pembroke, MA 02359
Tel: 800-932-4202 or 781-826-9060
Fax: 781-826-9062
[email protected]
www.fci-ophthalmics.com